Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINBLASTINE for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 94 adverse event reports in the FDA FAERS database where VINBLASTINE was used for Bladder cancer.

Most Reported Side Effects for VINBLASTINE

Side Effect Reports % Deaths Hosp.
Off label use 508 9.4% 125 148
Febrile neutropenia 498 9.2% 62 285
Neutropenia 416 7.7% 74 175
Drug ineffective 302 5.6% 68 62
Product use in unapproved indication 265 4.9% 66 73
Disease progression 262 4.9% 58 21
Pyrexia 259 4.8% 26 166
Neuropathy peripheral 258 4.8% 10 32
Nausea 215 4.0% 25 127
Vomiting 172 3.2% 24 105
Malignant neoplasm progression 170 3.2% 45 35
Second primary malignancy 170 3.2% 86 34
Thrombocytopenia 167 3.1% 57 62
Anaemia 165 3.1% 26 58
Hodgkin's disease 165 3.1% 19 48

Other Indications for VINBLASTINE

Hodgkin's disease (2,866) Product used for unknown indication (380) Langerhans' cell histiocytosis (164) Transitional cell carcinoma (116) Chemotherapy (86) Non-hodgkin's lymphoma (59) Hodgkin's disease nodular sclerosis (54) Lymphoma (54) Diffuse large b-cell lymphoma (52) Hodgkin's disease stage iv (50)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

VINBLASTINE Full Profile All Bladder cancer Drugs VINBLASTINE Demographics VINBLASTINE Timeline